The increase in angiotensin II levels [15] consequent to the dysregulation of the renin-angiotensin system (RAS), as well as the significant release of proinflammatory cytokines, highlights the ability of SARS-CoV-2 to enhance inflammatory responses, which might lead to lung damage and neurological consequences in severe forms of COVID-19. This evidence concerns the gene AGT and COVID-19.